18 reports

Insulin Pumps Outlook Type I Diabetes: Type I diabetes is an autoimmune disease that destroys the insulin producing beta cells in the pancreas of the human body.

  • Insulin Delivery
  • Type 1 Diabetes
  • World
  • Market Size
  • Animas Corporation
  • Vendor landscape

Develops a platform technology to treat autoimmune diseases.

  • Type 1 Diabetes
  • World
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

A chronic autoimmune disease.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.

A chronic autoimmune disease.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

A chronic autoimmune disease.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

A chronic autoimmune disease.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group

A chronic autoimmune disease.

  • Type 1 Diabetes
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group
  • 5.1 BIBLIOGRAPHY

A chronic autoimmune disease.

  • Type 1 Diabetes
  • Canada
  • North America
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • RECOMBINANT PEPTIDE FOR AUTOIMMUNE DISEASES - DRUG PROFILE
  • BIRCHBIOMED INC

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2017, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline landscape. Type...

  • Chronic Disease
  • Type 1 Diabetes
  • United States
  • World
  • Company
  • Small Molecule to Agonize AhR for Type 1 Diabetes and Graft Versus Host Disease - Drug Profile
  • Drug to Agonize Aryl Hydrocarbon Receptor for Rheumatoid Arthritis - Drug Profile

These cells are functional and suppress the development of experimental spontaneous autoimmune diseases.

  • Therapy
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Shenogen Pharma Group
  • Business Description
  • PARTNERSHIPS

T##D is a chronic autoimmune disease that must be managed throughout the day and night.

  • Diabetes
  • Pharmaceutical
  • Type 1 Diabetes
  • United States
  • Sernova Corp.

Currently the founder and CEO of Octave Bioscience, an early-stage diagnostics company focused on neurodegenerative diseases, Hagstrom previously served as president and CEO of Crescendo Bioscience, which concentrated on specialty diagnostics for autoimmune and inflammatory

  • Monoclonal Antibody
  • Type 1 Diabetes
  • United States
  • Company
  • GlobalData's company

The company will first be evaluating foralumab in two clinical indications: ##) graft vs host disease, and ##) ulcerative colitis, an inflammatory bowel disease.

  • Glycoprotein
  • Type 1 Diabetes
  • World
  • Product Initiative
  • Xencor, Inc.
  • Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma

It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma.

  • Pharmaceutical
  • Type 1 Diabetes
  • United States
  • Company
  • XERIS Pharmaceuticals, Inc.
  • Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma

It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma.

  • Pharmaceutical
  • Type 1 Diabetes
  • United States
  • Company
  • XERIS Pharmaceuticals, Inc.
  • PARTNERSHIPS
  • SFC FLUIDICS ENTERS INTO DEVELOPMENT PARTNERSHIP WITH JUVENILE DIABETES RESEARCH FOUNDATION

It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma.

  • Diabetes
  • Medical Device
  • Medical Equipment
  • Type 1 Diabetes
  • United States
  • 6 Key Events and History

Those include- LX##, an orally-delivered small molecule compound for the treatment of irritable Other Programs LX##, an orally-delivered small molecule compound for the of treatment bowel syndrome autoimmune disease topically-delivered small molecule compound for LX##, the of

  • Clinical Trial
  • Endocrine Disease
  • Pharmaceutical
  • Therapy
  • Type 1 Diabetes
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY ATLANTIC BIO SCI LLC, H2 2016
  • TYPE 1 DIABETES (JUVENILE DIABETES)

It develops and offers products and technologies for the treatment of autoimmune diseases.

  • Biotechnology
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Company
  • Product Initiative